<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/271C23C7-F7D4-4004-9261-4FAD511E2C50"><gtr:id>271C23C7-F7D4-4004-9261-4FAD511E2C50</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:surname>Bertolotti</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105185860"><gtr:id>6C936BB6-F7B9-4352-A7CA-1BC3A09DFB9C</gtr:id><gtr:title>Understanding and preventing the deposition of misfolded proteins</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105185860</gtr:grantReference><gtr:abstractText>Alzheimer?s disease, Parkinson?s disease, Huntington?s disease, Amyotrophic Lateral Sclerosis and Prion disease are devastating and affect an increasing number of individuals in the ageing population. Each disease is caused by the progressive dysfunction and death of specific nerve cells in selective regions of the brain due to the accumulation of proteins of aberrant shape. While it is now clear that the formation of the protein deposits is toxic to nerve cells, why and how they form is unclear. We have provided novel insights into this process My lab contributed to our current understanding of the mechanisms governing aggregation of disease-related proteins and discovered potent strategies to rescue from protein misfolding stress.
Ultimately, this work may provide an opportunity to develop mechanism-based therapies.</gtr:abstractText><gtr:technicalSummary>Neurodegenerative diseases such as Alzheimer?s disease (AD), Parkinson?s disease (PD), Huntington?s disease (HD) and Amyotrophic Lateral Sclerosis (ALS) are devastating and affect an increasing number of individuals in the ageing population. Theses diseases are caused by the progressive dysfunction and death of specific nerve cells in selective regions of the brain due to the accumulation of specific proteins of aberrant shape. 

The disease-causing proteins are expressed throughout life but neurodegenerative diseases are mostly late-onset. This suggests that the different disease-causing proteins gradually become detrimental over time. While it is now well established that misfolded proteins cause distinct neurodegenerative diseases, why they accumulate remains largely unclear. Cells normally strive to ensure that proteins get correctly folded and indeed all cells have powerful and sophisticated protein quality control systems that very efficiently handle potentially harmful proteins for decades. However, the protein quality control mechanisms seem to gradually fail with age, leading to the accumulation of misfolded proteins with the resulting catastrophic consequences for cells and organisms.

My long-term goal is to understand the mechanisms that govern the deposition of misfolding-prone proteins, why they persist in aged cells and to identify strategies that could reduce the burden of misfolded proteins for cells and organisms. My work focuses on fundamental cell biological processes with the view that some of our discoveries will benefit human health.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-08-14</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>6676815</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Speaker at the MRC LMB Alumni Symposium 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EA0043A8-52ED-4398-86C3-D2ECC40FD9A7</gtr:id><gtr:impact>The alumni Symposium was a Celebration of over 50 years of the MRC Laboratory of Molecular Biology since the original building was built in 1962. The meeting was organised to welcome all alumni from the LMB back to Cambridge. My talk for the meeting was called &amp;quot;Surviving Protein Quality Control Failure:

A lot of interest generated from the talk I gave by Alumni that attended the session</gtr:impact><gtr:outcomeId>5464a1b926c7a1.88188095</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LMB Open Day in 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>53DCD782-0CBE-46A3-9636-E9EA77590BEC</gtr:id><gtr:impact>Lab tour during the LMB Open Day. We had many visitors to our display showing cells with and without agregates to the public under microscopes

The work generated a lot of interest from the public that attended the LMB Open Day</gtr:impact><gtr:outcomeId>5464a2a149fc04.19869493</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100204</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT</gtr:description><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:fundingRef>A853/0076</gtr:fundingRef><gtr:id>A80FBDE2-8A99-4201-999C-4AEE269EBD47</gtr:id><gtr:outcomeId>dYVpKnjWydK</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>182000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA Research Grant (ZZ)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:fundingRef>Bertolotti/Apr11/6072</gtr:fundingRef><gtr:id>4AFBC929-A7F1-4BF1-8661-27850C9D348B</gtr:id><gtr:outcomeId>DLGZiHM1FAa0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14900</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship stipend (CM)</gtr:description><gtr:fundingOrg>Louis-Jeantet Prize for Medicine</gtr:fundingOrg><gtr:id>1C8C4CE0-27BB-47C7-ABD7-01CF1C0915F4</gtr:id><gtr:outcomeId>hDs2pce2D1q0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8908</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Summer Student Funding (MP)</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Louis-Jeantet Foundation</gtr:fundingOrg><gtr:fundingRef>CO227</gtr:fundingRef><gtr:id>776C381A-40A4-4084-979C-CE25573125EB</gtr:id><gtr:outcomeId>56d87a04668876.45615496</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100204</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development Gap Fund</gtr:description><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>AA7BBC4A-47B3-4EB6-B8CF-CEDA6012DF6C</gtr:id><gtr:outcomeId>1D27FC82A1E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EMBO Young Investigator Programme</gtr:description><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>CCA35613-DD6B-48C7-BB6A-A7E6960E3BF4</gtr:id><gtr:outcomeId>33B0A449A200</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1431408</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starter Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>ERC-2012-StG-309516</gtr:fundingRef><gtr:id>A9C95EBD-2D86-43D1-AC7C-48FF1A825AFB</gtr:id><gtr:outcomeId>T8LduspcFpc</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Small molecules, selective inhibitors of a serine threonine phosphatase, PPP1R15A-PP1 to prevent protein misfolding diseases</gtr:description><gtr:grantRef>MC_U105185860</gtr:grantRef><gtr:id>82C4FF4A-77B5-427B-B9A6-ABC5D4B67649</gtr:id><gtr:impact>The molecule has received an orphan drug designation</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df01509b8f95.10313637</gtr:outcomeId><gtr:patentId>WO 2014108520 A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>96E839F6-E618-4B4C-B470-741D11A00EF0</gtr:id><gtr:title>Decoding the Protein Destruction Code: A Panoramic View.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46ebdcad80a55cb532daf13636b3edbc"><gtr:id>46ebdcad80a55cb532daf13636b3edbc</gtr:id><gtr:otherNames>Pilla E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>58bd83550f90f1.22928237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95C0922A-CC9F-4C9E-8B0D-42E17D247E49</gtr:id><gtr:title>Self-propagation and transmission of misfolded mutant SOD1: prion or prion-like phenomenon?</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2148e880746fe123bfb8ce43dc44fe4"><gtr:id>a2148e880746fe123bfb8ce43dc44fe4</gtr:id><gtr:otherNames>M?nch C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_14244_24_21471733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56579087-4447-4DCE-86D8-397FBAD3E7A9</gtr:id><gtr:title>An inducible chaperone adapts proteasome assembly to stress.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4526ea4226c603daad15e1332cf7c1"><gtr:id>bd4526ea4226c603daad15e1332cf7c1</gtr:id><gtr:otherNames>Hanssum A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>doi_55f985985e74dced</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>093EC405-9FFE-4ED6-BCB9-F209E7C4F484</gtr:id><gtr:title>Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fe2cc29edff48d5e16c3e923f1453ed"><gtr:id>1fe2cc29edff48d5e16c3e923f1453ed</gtr:id><gtr:otherNames>Tsaytler P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>MTo9w59AtS6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F28DF4-C04A-47FE-980A-8D9A5FA9724D</gtr:id><gtr:title>qMotor, a set of rules for sensitive, robust and quantitative measurement of motor performance in mice.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97541fb0382ce1c6655b62c222c24996"><gtr:id>97541fb0382ce1c6655b62c222c24996</gtr:id><gtr:otherNames>Luh LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>5a6dc38b483280.03930457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4F267B0-B0A9-40F8-9099-9595A40E96EF</gtr:id><gtr:title>Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2148e880746fe123bfb8ce43dc44fe4"><gtr:id>a2148e880746fe123bfb8ce43dc44fe4</gtr:id><gtr:otherNames>M?nch C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>bXSUGAKgGJu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>156B6FE4-50B0-499C-96CB-1039941DC23B</gtr:id><gtr:title>Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicity.</gtr:title><gtr:parentPublicationTitle>Biotechnology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7dbc49e8053575971a71858cbd44a73"><gtr:id>c7dbc49e8053575971a71858cbd44a73</gtr:id><gtr:otherNames>Dehay B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1860-6768</gtr:issn><gtr:outcomeId>9BE6B17181E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A95DEE7A-10DD-4749-B9AB-3016C59B0146</gtr:id><gtr:title>Surviving protein quality control catastrophes--from cells to organisms.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fba8ba0055b66c9577783fd8d563c58"><gtr:id>0fba8ba0055b66c9577783fd8d563c58</gtr:id><gtr:otherNames>Schneider K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56cef7c4908681.73506097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34FC70CA-4DE8-4F9E-96E5-4874FE207250</gtr:id><gtr:title>Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4777c6e26cce3ad4799e7467acb2d221"><gtr:id>4777c6e26cce3ad4799e7467acb2d221</gtr:id><gtr:otherNames>Sibilla C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1943-0264</gtr:issn><gtr:outcomeId>5a82be6cdaca72.27636655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78CD10A3-315D-4CF3-A175-6EE34D88B995</gtr:id><gtr:title>Coping with Protein Quality Control Failure.</gtr:title><gtr:parentPublicationTitle>Annual review of cell and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46ebdcad80a55cb532daf13636b3edbc"><gtr:id>46ebdcad80a55cb532daf13636b3edbc</gtr:id><gtr:otherNames>Pilla E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1081-0706</gtr:issn><gtr:outcomeId>5a82beed004568.75490448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F4F133-7120-459D-A766-83F95EA9F3F5</gtr:id><gtr:title>Failure of amino acid homeostasis causes cell death following proteasome inhibition.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15a86f38b5c2da59a8fa9083087315b8"><gtr:id>15a86f38b5c2da59a8fa9083087315b8</gtr:id><gtr:otherNames>Suraweera A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_14244_24_22959274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55E0A894-7E81-4626-BC89-D90EE86FFBE3</gtr:id><gtr:title>Prion-like protein aggregates exploit the RHO GTPase to cofilin-1 signaling pathway to enter cells.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31ab01452b87d7a4d4d4cdbc1275741f"><gtr:id>31ab01452b87d7a4d4d4cdbc1275741f</gtr:id><gtr:otherNames>Zhong Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5a9e78db31e5b7.13817111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34BF094C-F72B-43DD-92F5-DB93795B86DE</gtr:id><gtr:title>Propagation of the prion phenomenon: beyond the seeding principle.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2148e880746fe123bfb8ce43dc44fe4"><gtr:id>a2148e880746fe123bfb8ce43dc44fe4</gtr:id><gtr:otherNames>M?nch C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_14244_24_22245492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C71A4BDD-E4CD-438B-B21F-9ECBBFC9E6B4</gtr:id><gtr:title>Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2148e880746fe123bfb8ce43dc44fe4"><gtr:id>a2148e880746fe123bfb8ce43dc44fe4</gtr:id><gtr:otherNames>M?nch C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>RcmokeMV31R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54EF722F-86E3-441F-B6B8-C953F8D5B919</gtr:id><gtr:title>Protein misfolding in neurodegenerative diseases</gtr:title><gtr:parentPublicationTitle>Dementia Forum</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55f007dab1e4eb038cb24efcfc6ade59"><gtr:id>55f007dab1e4eb038cb24efcfc6ade59</gtr:id><gtr:otherNames>Bertolotti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>isEF9WEPXwD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21B59D1A-B229-4AE8-84BD-BA18FB627032</gtr:id><gtr:title>An evolutionarily conserved pathway controls proteasome homeostasis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbb55488baa029ce22f1038f9adb85bf"><gtr:id>dbb55488baa029ce22f1038f9adb85bf</gtr:id><gtr:otherNames>Rousseau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>585d6b7c2a7ab9.08362337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1164245C-6A35-4780-AFEA-CF1E62906F03</gtr:id><gtr:title>Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5c24f53bfaec60325b2060751910882"><gtr:id>d5c24f53bfaec60325b2060751910882</gtr:id><gtr:otherNames>Rousseau E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>1454789D418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1885DE6-DD80-4226-A2B5-57E650E5D131</gtr:id><gtr:title>Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d30f4552a8979c1ef7261e4dce96344"><gtr:id>8d30f4552a8979c1ef7261e4dce96344</gtr:id><gtr:otherNames>Das I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5675e21ba2dac</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15E95EAE-E217-4A16-AFF0-D3B1DB327C4B</gtr:id><gtr:title>Exploiting the selectivity of protein phosphatase 1 for pharmacological intervention.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fe2cc29edff48d5e16c3e923f1453ed"><gtr:id>1fe2cc29edff48d5e16c3e923f1453ed</gtr:id><gtr:otherNames>Tsaytler P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>pm_14244_24_22340633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CA6E202-34F3-4C24-B42E-9BF47FE5F6D7</gtr:id><gtr:title>Sustained translational repression by eIF2a-P mediates prion neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a45accd461e1e9d4d6142f0ea8b377b"><gtr:id>4a45accd461e1e9d4d6142f0ea8b377b</gtr:id><gtr:otherNames>Moreno JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_14244_24_22622579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16E37D55-9604-40AB-9D58-47DEF52D360F</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>56cf1a7a51a955.06065409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0092852C-40C2-4C0C-B4CB-9D872568D7E7</gtr:id><gtr:title>Decoding the selectivity of eIF2a holophosphatases and PPP1R15A inhibitors.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e04d2ad0f0b433775b8db6a840952eff"><gtr:id>e04d2ad0f0b433775b8db6a840952eff</gtr:id><gtr:otherNames>Carrara M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>5a82beb6780585.94414310</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105185860</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>